TCT 2021 | SUGAR Trial: Polymer-Free Stent in Diabetes

In CAD patients with diabetes the polymer-free amphilimus-eluting stent resulted non-inferior to the polymer-based zotarolimus-eluting Resolute Onyx. This new device, in addition to ultrathin struts, has already been found non-inferior to the Resolute Integrity in the general population at 3-year followup. Researchers believe that the new amphiphilic carrier might be especially useful in diabetic patients<a href="https://solaci.org/en/2021/11/09/tct-2021-sugar-trial-polymer-free-stent-in-diabetes/" title="Read more" >...</a>

10 Years Treating Bifurcations: Have We Made Progress?

Bifurcations have been, are and will be challenging. However, we have to admit we have gained experience and have more tools than pioneer interventionists and many of the early experts who have made history.  This study assessed the ten-year trends in coronary bifurcation percutaneous coronary intervention (PCI) looking at patient and lesion characteristics, devices used,<a href="https://solaci.org/en/2021/10/26/10-years-treating-bifurcations-have-we-made-progress/" title="Read more" >...</a>

Access all contents of the 11th ProEducar Fellows Course

During the virtual SOLACI-CACI 2021 Congress, the 11th ProEducar Fellows Course—SOLACI’s traditional activity aimed at expanding knowledge and providing didactic tools for all interventional trainees in Latin America—was held. The course was a huge success: almost 1500 people accessed the Andreas Gruentzig Virtual Room where the activity took place. Furthermore, over 35 prestigious speakers from all<a href="https://solaci.org/en/2021/09/15/access-all-contents-of-the-11th-proeducar-fellows-course/" title="Read more" >...</a>

SOLACI-CACI 2021 | SCAI Session

✔️ SCAI Session (Society for Cardiovascular Angiography and Interventions) in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 00:03 – STEMI: Approach to Left Main Culprit – Dr. Timothy Henry. 15:38 – Gender Disparities in STEMI – Dr. Cindy Grines. 29:52 – Optimal DAPT Post Complex PCI – Dr. George Dangas. 47:01 – PCI or CABG for<a href="https://solaci.org/en/2021/09/15/solaci-caci-2021-scai-session/" title="Read more" >...</a>

SOLACI-CACI 2021 | CCI Session

✔️ Watch again the Catheterization and Cardiovascular Interventions (CCI) Session in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 01:44 – The Hybrid Algorithm in Complex Chronic Total Occlusion Percutaneous Coronary Intervention: Experience of a Latin-American Centre – Héctor Hugo Escutia Cuevas 21:12 – SYNTAX score II application compared to GRACE score for prediction of Heart Failure<a href="https://solaci.org/en/2021/09/14/solaci-caci-2021-cci-session-2/" title="Read more" >...</a>

The Most Read Articles in August in Interventional Cardiology

01- Best Revascularization Strategy in Patients with Left Ventricular Deterioration Multivessel disease associated to ventricular function deterioration is challenging in terms of risk, when choosing a revascularization strategy.  Read also HERE 02- SOLACI Renewed Authorities During the SOLACI-CACI 2021 Congress After a massive event attended by thousands of people, the Latin American Society of Interventional Cardiology renewed its authorities for<a href="https://solaci.org/en/2021/09/10/the-most-read-articles-in-august-in-interventional-cardiology/" title="Read more" >...</a>

¿Endarterectomía o angioplastia carotídea? la pregunta sigue motivando más estudios

Non-Culprit Vessel Angioplasty in the Elderly: Choosing the Right Cases Is Important

This large analysis found no benefit at a 1-year follow-up to angioplasty of non-culprit vessels in elderly patients admitted with ST-segment elevation myocardial infarction. The COMPLETE study was presented at the European Society of Cardiology 2019 Congress (and simultaneously published in NEJM) with evidence that seemed to leave no doubt regarding this issue. However, new<a href="https://solaci.org/en/2021/09/09/non-culprit-vessel-angioplasty-in-the-elderly-choosing-the-right-cases-is-important/" title="Read more" >...</a>

FLOWER-MI Sub-Studies Coming Out Generate More Questions about FFR

The FLOWER-MI (presented simultaneously at ACC 2021 and NEJM) hit FFR hard. Its outcomes showed that STEMI patients presenting other non-culprit lesions did not benefit from FFR guided revascularization vs PCI. As it happens with most large studies with unexpected results in the general population, the sub-studies that follow select better samples and, as a<a href="https://solaci.org/en/2021/09/08/flower-mi-sub-studies-coming-out-generate-more-questions-about-ffr/" title="Read more" >...</a>

Complete Revascularization after Pharmacoinvasive Strategy

Patients initially receiving pharmacoinvasive strategy for ST elevation myocardial infarction (STEMI) also presenting multivessel disease consistently benefit from complete revascularization. This benefit is similar to that of primary PCI.   The COMPLETE showed that staged non-culprit lesion percutaneous coronary intervention (PCI) reduced major cardiovascular events in STEMI patients with multivessel coronary artery disease. This benefit was<a href="https://solaci.org/en/2021/08/25/complete-revascularization-after-pharmacoinvasive-strategy/" title="Read more" >...</a>

revascularizacion incompleta en cirugia no cardiaca

Best Revascularization Strategy in Patients with Left Ventricular Deterioration

Multivessel disease associated to ventricular function deterioration is challenging in terms of risk, when choosing a revascularization strategy.  According to this recent analysis of the SCAAR registry published in the European Heart Journal, long term followup seems to justify taking a higher risk initially, higher risk being myocardial revascularization surgery (CABG). The study looked at<a href="https://solaci.org/en/2021/08/11/best-revascularization-strategy-in-patients-with-left-ventricular-deterioration/" title="Read more" >...</a>